Skip to main content

Treatment of Liver and Gastric Cancer Using Nanoemulsion

  • Chapter
  • First Online:
Current Trends in Green Nano-emulsions

Abstract

Cancer is one of the leading causes of death worldwide. Current chemotherapy challenges the lack of selectivity, cytotoxicity, the development of multi-drug resistance, and the proliferation of stem-like cells. One of the leading causes of new cancer cases and cancer-related fatalities is a group of deadly malignant tumors known as liver and gastric cancer. Advanced gastric cancer is classified as having liver metastases and is one of the deadliest conditions with a dismal prognosis. As gastric cancer with liver metastases is incurable, systematic chemotherapy is the primary line of treatment, although surgery is typically used to relieve severe gastrointestinal symptoms. The main method for delivering various medications, nucleic acids, and imaging agents is nanoemulsion (NE). Nevertheless, NE is created through many functions, including surface changes and the encapsulation of active cancer-fighting substances. Because of their excellent characteristics to solubilize hydrophobic chemotherapeutics, thermodynamic stability, biocompatibility, and target ability, NEs are an appealing platform for cancer treatment. With their submicron-dispersed colloids in the continuous phase, NEs may be able to perform various tasks, which helps to overcome biological obstacles that prevent traditional chemotherapeutic drug delivery from reaching the target location of cancers. This chapter provides a brief overview of the use of NEs in treating gastric and liver cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Abdu F, Alshehri W, Alkhatib MH (2017) The anticancer activity of the combination therapy of gem and dox encapsulated in a NE. Polym Sci 3(4). https://doi.org/10.4172/2471-9935-C1-006

  2. Abu-Fayyad A, Nazzal S (2017) Gem-Vitamin E conjugates: synthesis, characterization, entrapment into NEs, and in-vitro deamination and antitumor activity. Int J Pharm 528(1–2):463. https://doi.org/10.1016/J.IJPHARM.2017.06.031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Ahmad U, Akhtar J, Singh SP, Badruddeen B, Ahmad FJ, Siddiqui S, Wahajuddin W (2018) Silymarin NE against human hepatocellular carcinoma: development and optimization. Artif Cells, Nanomed Biotechnol 46(2):231–241. https://doi.org/10.1080/21691401.2017.1324465

    Article  CAS  PubMed  Google Scholar 

  4. Alavizadeh SH, Hosseinzadeh H (2014) Bioactivity assessment and toxicity of crocin: a comprehensive review. Food Chem Toxicol: Int J Publ Brit Indus Biol Res Assoc 64:65–80. https://doi.org/10.1016/J.FCT.2013.11.016

    Article  CAS  Google Scholar 

  5. Alkhatib MH, Alkreathy HM, Balamash KS, Abdu F (2016) Antitumor activity of doxe-loaded NE against ehrlich ascites carcinoma-bearing mice. Trop J Pharm Res 15(5):937–943. https://doi.org/10.4314/TJPR.V15I5.6

    Article  CAS  Google Scholar 

  6. Alkhatib MH, Alshehri WS, Abdu FB (2018) In vivo evaluation of the anticancer activity of the gem and dox combined in a NE. J Pharm Bioallied Sci 10(1):35–42. https://doi.org/10.4103/JPBS.JPBS_225_17

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Alnajjar AsmaM, Elsiesy HussienA (2015) Natural products and hepatocellular carcinoma: a review. Hepatoma Res 1(3):119. https://doi.org/10.4103/2394-5079.167379

    Article  CAS  Google Scholar 

  8. Cao H, Wang Y, He X, Zhang Z, Yin Q, Chen Y, Yu H, Huang Y, Chen L, Xu M, Gu W, Li Y (2015) Codelivery of sorafenib and curcumin by directed self-assembled nanoparticles enhances therapeutic effect on hepatocellular carcinoma. Mol Pharm 12(3):922–931. https://doi.org/10.1021/MP500755J

  9. Choudhury H, Pandey M, Gorain B, Chatterjee B, Madheswaran T, Mak SMKK, Tambuwala M, Chourasia MK, Kesharwani P (2019) NEs as effective carriers for the treatment of lung cancer. Nanotechnol-Based Target Drug Deliv Syst Lung Cancer 217–247. https://doi.org/10.1016/B978-0-12-815720-6.00009-5

  10. Efferth T (2017) From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46:65–83. https://doi.org/10.1016/J.SEMCANCER.2017.02.009

    Article  CAS  PubMed  Google Scholar 

  11. El-Readi MZ, Althubiti MA (2019) Cancer nanomedicine: a new era of successful targeted therapy. J Nanomater. https://doi.org/10.1155/2019/4927312

  12. El-Sherbiny M, Eldosoky M, El-Shafey M, Othman G, Elkattawy HA, Bedir T, Elsherbiny NM (2018) Vitamin D NE enhances hepatoprotective effect of conventional Vitamin D in rats fed with a high-fat diet. Chem Biol Interact 288:65–75. https://doi.org/10.1016/J.CBI.2018.04.010

    Article  CAS  PubMed  Google Scholar 

  13. Esperón-Rojas AA, Baeza-Jiménez R, Cano-Sarmiento C, García HS (2017) Structured mono- and diacylglycerols with a high content of medium chain fatty acids. J Oleo Sci 66(9):991–996. https://doi.org/10.5650/JOS.ESS17010

    Article  PubMed  Google Scholar 

  14. Esperón-Rojas, Alessa A, Baeza-Jiménez R, García HS (2019) Preparation of curcumin-carrying NEs using mono- and diacylglycerides enzymatically structured with bioactive fatty acids. 38(2):93–103. https://doi.org/10.1080/10242422.2019.1646254

  15. Fan M, Liang X, Li Z, Wang H, Yang D, Shi B (2015) Chlorambucil gem conjugate nanomedicine for cancer therapy. Eur J Pharm Sci: Off J Eur Federat Pharm Sci 79:20–26. https://doi.org/10.1016/J.EJPS.2015.08.013

    Article  CAS  Google Scholar 

  16. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359–E386. https://doi.org/10.1002/IJC.29210

    Article  CAS  PubMed  Google Scholar 

  17. Ganta S, Talekar M, Singh A, Coleman TP, Amiji MM (2014) NEs in translational research-opportunities and challenges in targeted cancer therapy. AAPS PharmSciTech 15(3):694–708. https://doi.org/10.1208/S12249-014-0088-9

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gorain B, Choudhury H, Nair AB, Dubey SK, Kesharwani P (2020) Theranostic application of NEs in chemotherapy. Drug Discov Today 25(7):1174–1188. https://doi.org/10.1016/J.DRUDIS.2020.04.013

    Article  CAS  PubMed  Google Scholar 

  19. Herneisey M, Mejia G, Pradhan G, Dussor G, Price T, Janjic J (2018) Resveratrol NEs target inflammatory macrophages to prevent. J Pain 19(3):S75-76. https://doi.org/10.1016/j.jpain.2017.12.173

    Article  Google Scholar 

  20. Izadiyan Z, Basri M, Masoumi HRF, Karjiban RA, Salim N, Shameli K (2017) Modeling and optimization of NE containing sorafenib for cancer treatment by response surface methodology. Chem Central J 11(1). https://doi.org/10.1186/S13065-017-0248-6

  21. Jaganathan SK, Mazumdar A, Mondhe D, Mandal M (2011) Apoptotic effect of eugenol in human colon cancer cell lines. Cell Biol Int 35(6):607–615. https://doi.org/10.1042/CBI20100118

    Article  CAS  PubMed  Google Scholar 

  22. Jaiswal M, Dudhe R, Sharma PK (2015) NE: an advanced mode of drug delivery system. 3 Biotech 5(2):123. https://doi.org/10.1007/S13205-014-0214-0

  23. Kentish S, Wooster TJ, Ashokkumar M, Balachandran S, Mawson R, Simons L (2008) The use of ultrasonics for NE preparation. Innov Food Sci Emerg Technol 9(2):170–175. https://doi.org/10.1016/J.IFSET.2007.07.005

    Article  CAS  Google Scholar 

  24. Kim S, Choi MG, Lee HS, Lee SK, Kim SH, Kim WW, Hur SM, Kim JH, Choe JH, Nam SJ, Yang JH, Kem S, Lee JE, Kim JS (2009) Silibinin suppresses TNF-α-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway. Molecules 14(11):4300–4311. https://doi.org/10.3390/MOLECULES14114300

  25. Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G (2021) Nanotechnology approaches for global infectious diseases. Nat Nanotechnol 16(4):369–384. https://doi.org/10.1038/s41565-021-00866-8

  26. Li JH, Xie XY, Zhang L, Le F, Ge NL, Li LX, Gan YH, Chen Y, Zhang JB, Xue TC, Chen RX, Xia JL, Zhang BH, Ye SL, Wang YH, Ren ZG (2015) Oxaliplatin and 5-FU hepatic infusion with lipiodolized chemoembolization in large hepatocellular carcinoma. World J Gastroenterol: WJG 21(13):3970. https://doi.org/10.3748/WJG.V21.I13.3970

  27. Ligeret H, Brault A, Vallerand D, Haddad Y, Haddad PS (2008) Antioxidant and mitochondrial protective effects of silibinin in cold preservation-warm reperfusion liver injury. J Ethnopharmacol 115(3):507–514. https://doi.org/10.1016/J.JEP.2007.10.024

    Article  CAS  PubMed  Google Scholar 

  28. Luo Z, Rong Z, Huang C (2019) Surgery strategies for gastric cancer with liver metastasis. Front Oncol 9. https://doi.org/10.3389/FONC.2019.01353

  29. Majeed H, Antoniou J, Fang Z (2014) Apoptotic effects of eugenol-loaded NEs in human colon and liver cancer cell lines. Asian Pac J Cancer Prevent: APJCP 15(21):9159–9164. https://doi.org/10.7314/APJCP.2014.15.21.9159

    Article  Google Scholar 

  30. Mehrnia MA, Jafari SM, Makhmal-Zadeh BS, Maghsoudlou Y (2016) Crocin loaded nano-emulsions: factors affecting emulsion properties in spontaneous emulsification. Int J Biol Macromol 84:261–267. https://doi.org/10.1016/J.IJBIOMAC.2015.12.029

    Article  CAS  PubMed  Google Scholar 

  31. Mohapatra P, Chandrasekaran N, Mukherjee A (2021) NE: a boon to liver and gastric cancer treatment (May):307–329. https://doi.org/10.4018/978-1-7998-8378-4.ch014

  32. Naseema A, Kovooru L, Behera AK, Kumar KPP, Srivastava P (2021) A critical review of synthesis procedures, applications and future potential of NEs. Adv Colloid Interf Sci 287:102318. https://doi.org/10.1016/J.CIS.2020.102318

  33. Noureini SK, Wink M (2012) Antiproliferative effects of crocin in HepG2 cells by telomerase inhibition and HTERT down-regulation. Asian Pac J Cancer Prevent: APJCP 13(5):2305–2309. https://doi.org/10.7314/APJCP.2012.13.5.2305

    Article  Google Scholar 

  34. Pangeni R, Choi SW, Jeon OC, Byun Y, Park JW (2016) Multiple NE system for an oral combinational delivery of oxaliplatin and 5-FU: preparation and in vivo evaluation. Int J Nanomed 11:6379. https://doi.org/10.2147/IJN.S121114

    Article  CAS  Google Scholar 

  35. Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting CAMP phosphodiesterases. Cell 148(3):421–433. https://doi.org/10.1016/J.CELL.2012.01.017

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Plaza-Oliver M, Santander-Ortega MJ, Lozano MV (2021) Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 11(2):471–497. https://doi.org/10.1007/S13346-021-00908-7

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Praveen Kumar G, Divya A (2015) NE based targeting in cancer therapeutics. Med Chem, Open Access J 5(6):272–284. https://doi.org/10.4172/2161-0444.1000275

  38. Pucek A, Tokarek B, Waglewska E, Bazylińska U (2020) Recent advances in the structural design of photosensitive agent formulations using ‘Soft’ colloidal nanocarriers. Pharmaceutics 12(6):587. https://doi.org/10.3390/PHARMACEUTICS12060587

  39. Rumgay H, Arnold M, Ferlay J, Lesi O, Cabasag CJ, Vignat J, Laversanne M, McGlynn KA, Soerjomataram I (2022) Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol 77(6):1598–1606. https://doi.org/10.1016/j.jhep.2022.08.021

    Article  PubMed  PubMed Central  Google Scholar 

  40. Sánchez-López E, Guerra M, Dias-Ferreira J, Lopez-Machado A, Ettcheto M, Cano A, Espina M, Camins A, Garcia ML, Souto EB (2019) Current applications of NEs in cancer therapeutics. Nanomaterials (Basel, Switzerland) 9(6). https://doi.org/10.3390/NANO9060821

  41. Sarfarazi M, Jafari SM, Rajabzadeh G (2015) Extraction optimization of saffron nutraceuticals through response surface methodology. Food Anal Methods 8(9):2273–2285. https://doi.org/10.1007/S12161-014-9995-3

    Article  Google Scholar 

  42. Shamseddine A, Saleh A, Charafeddine M, Seoud M, Mukherji D, Temraz S, Sibai AM (2014) Cancer trends in Lebanon: a review of incidence rates for the period of 2003–2008 and projections until 2018. Popul Health Met 12(1):1–8. https://doi.org/10.1186/1478-7954-12-4/FIGURES/4

    Article  Google Scholar 

  43. Sugumar S, Nirmala J, Ghosh V, Anjali H, Mukherjee A, Chandrasekaran N (2013) Bio-based NE formulation, characterization and antibacterial activity against food-borne pathogens. J Basic Microbiol 53(8):677–685. https://doi.org/10.1002/JOBM.201200060

    Article  CAS  PubMed  Google Scholar 

  44. Tao R, Wang CZ, Ye JZ, Zhou H, Chen HX, Zhang CW (2016) Antibacterial, cytotoxic and genotoxic activity of nitrogenated and haloid derivatives of C50-C60 and C70-C120 polyprenol homologs. Lipids Health Dis 15(1):1–11. https://doi.org/10.1186/S12944-016-0345-X

  45. Tao R, Wang C, Zhang C, Li WJ, Zhou H, Chen H, Ye J (2018) Characterization, cytotoxicity, and genotoxicity of TiO2 and folate-coupled chitosan nanoparticles loading polyprenol-based NE. Biol Trace Elem Res 184(1):60–74. https://doi.org/10.1007/S12011-017-1184-Y

    Article  CAS  PubMed  Google Scholar 

  46. Upadhyay T, Ansari VA, Ahmad U, Sultana N, Akhtar J (2020) Exploring NE for liver cancer therapy. Curr Cancer Therapy Rev 16(4):260–268. https://doi.org/10.2174/1573394716666200302123336

    Article  CAS  Google Scholar 

  47. Xu T, Gao CC, Feng X, Yang Y, Shen X, Tang X (2019) Structure, physical and antioxidant properties of chitosan-gum arabic edible films incorporated with cinnamon essential oil. Int J Biol Macromol 134:230–236. https://doi.org/10.1016/J.IJBIOMAC.2019.04.189

    Article  CAS  PubMed  Google Scholar 

  48. Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y (2016) Is conversion therapy possible in stage iv gastric cancer: the proposal of new biological categories of classification. Gastric Cancer: Off J Int Gastric Cancer Assoc Japanese Gastric Cancer Associ 19(2):329–338. https://doi.org/10.1007/S10120-015-0575-Z

    Article  Google Scholar 

  49. Zhang Y, Ding J, Sun D, Sun H, Zhuang X, Chang F, Wang J, Chen X (2015) Thermogel-mediated sustained drug delivery for in situ malignancy chemotherapy. Mater Sci Eng C, Mater Biol Appl 49:262–268. https://doi.org/10.1016/J.MSEC.2015.01.026

    Article  CAS  PubMed  Google Scholar 

  50. Zhang Y, Guan DX, Shi J, Gao H, Li JJ, Zhao JS, Qiu L, Liu J, Li N, Guo WX, Xue J, Zhou FG, Wu MC, Wang HY, Xie D, Cheng SQ (2013) All-trans retinoic acid potentiates the chemotherapeutic effect of cisplatin by inducing differentiation of tumor initiating cells in liver cancer. J Hepatol 59(6):1255–1263. https://doi.org/10.1016/J.JHEP.2013.07.009

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kundan Kumar Chaubey .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yadav, S. et al. (2023). Treatment of Liver and Gastric Cancer Using Nanoemulsion. In: Husen, A., Bachheti, R.K., Bachheti, A. (eds) Current Trends in Green Nano-emulsions. Smart Nanomaterials Technology. Springer, Singapore. https://doi.org/10.1007/978-981-99-5398-1_11

Download citation

Publish with us

Policies and ethics